|
Published by: GlobalData
Published: Mar. 31, 2011 - 70 Pages
Table of Contents- Introduction
- Ankylosing Spondylitis
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Top Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Ankylosing Spondylitis
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Ankylosing Spondylitis Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Pfizer Inc.
- Clinical Trial Overview of Pfizer Inc.
- Merck & Co., Inc.
- Clinical Trial Overview of Merck & Co., Inc.
- Abbott Laboratories
- Clinical Trial Overview of Abbott Laboratories
- Johnson & Johnson
- Clinical Trial Overview of Johnson & Johnson
- F. Hoffmann-La Roche Ltd.
- Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
- Sanofi-Aventis
- Clinical Trial Overview of Sanofi-Aventis
- Novartis AG
- Clinical Trial Overview of Novartis AG
- Regeneron Pharmaceuticals, Inc.
- Clinical Trial Overview of Regeneron Pharmaceuticals, Inc.
- Revmatismesykehuset AS
- Clinical Trial Overview of Revmatismesykehuset AS
- Centocor B.V.
- Clinical Trial Overview of Centocor B.V.
- Array BioPharma Inc.
- Clinical Trial Overview of Array BioPharma Inc.
- POZEN Inc.
- Clinical Trial Overview of POZEN Inc.
- Mitsubishi Tanabe Pharma Corporation
- Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation
- Celltrion, Inc.
- Clinical Trial Overview of Celltrion, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd.
- AstraZeneca PLC
- Clinical Trial Overview of AstraZeneca PLC
- Amgen Inc.
- Clinical Trial Overview of Amgen Inc.
- Boehringer Ingelheim GmbH
- Clinical Trial Overview of Boehringer Ingelheim GmbH
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Charite University
- Clinical Trial Overview of Charite University
- Charite University
- Clinical Trial Overview of Charite University
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Tel-Aviv Sourasky Medical Center
- Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
- Chinese University of Hong Kong
- Clinical Trial Overview of Chinese University of Hong Kong
- Sun Yat-sen University
- Clinical Trial Overview of Sun Yat-sen University
- University of Zurich
- Clinical Trial Overview of University of Zurich
- University of Sao Paulo
- Clinical Trial Overview of University of Sao Paulo
- Goteborg University
- Clinical Trial Overview of Goteborg University
- Academic Medical Center
- Clinical Trial Overview of Academic Medical Center
- Chung Shan Medical University
- Clinical Trial Overview of Chung Shan Medical University
- Rehazentrum Bad Eilsen
- Clinical Trial Overview of Rehazentrum Bad Eilsen
- The University of Queensland
- Clinical Trial Overview of The University of Queensland
- Swansea University
- Clinical Trial Overview of Swansea University
- Asan Medical Center
- Clinical Trial Overview of Asan Medical Center
- Association de Recherche Clinique en Rhumatologie
- Clinical Trial Overview of Association de Recherche Clinique en Rhumatologie
- Imperial College London
- Clinical Trial Overview of Imperial College London
- Hvidovre University Hospital
- Clinical Trial Overview of Hvidovre University Hospital
- University Hospital, Tours
- Clinical Trial Overview of University Hospital, Tours
- Stanford University
- Clinical Trial Overview of Stanford University
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Zone, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Europe, Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, North America, Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, BRIC Countries, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Phase, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Withdrawn Clinical Trials, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Terminated Clinical Trials, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011**
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Revmatismesykehuset AS, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centocor B.V., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by POZEN Inc., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celltrion, Inc., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Goteborg University, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chung Shan Medical University, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rehazentrum Bad Eilsen, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Queensland, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Swansea University, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Association de Recherche Clinique en Rhumatologie, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011*
- List of Figures
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, BRIC Countries (%), 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011*
- Ankylosing Spondylitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Ankylosing Spondylitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- GlobalData Methodology
AbstractAnkylosing Spondylitis Global Clinical Trials Review, Q1, 2011
Summary
GlobalData's clinical trial report, “Ankylosing Spondylitis Global Clinical Trials Review, Q1, 2011"" provides data on the Ankylosing Spondylitis clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Ankylosing Spondylitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Ankylosing Spondylitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope - Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
Reasons to buy - Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Get full details about this report >>
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports,
company profiles and country profiles from over 720 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
|
|
